Variant · Snv
STAT3 NM_139276.3(STAT3):c.1654-11C>G
CI-VAR-00006944Explore in graph →NM_139276.3:c.1654-11C>GClinVar 36787 rs17882035
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 36787 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Hyper-IgE recurrent infection syndrome 1, autosomal dominant; STAT3 gain of function; Squamous cell carcinoma of the head and neck; Thymoma; Sarcoma; Lung cancer; Uterine corpus endometrial carcinoma; Cervical cancer | germline | 6 | Feb 01, 2026 | clinvar |